Skip to main content

Hudson Bay Capital Management LP

Position in BMY — Bristol Myers Squibb Co

CIK 1393825 STAMFORD, CT

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,257,834
+$3,257,834 QoQ
Shares Held
56,540
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#667
of 2,497 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$6,065,000
PutShares
100,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $396,101,149 across 12 Drug Manufacturers - General names. BMY ranks #7 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 BMY
Bristol Myers Squibb Co
This page
56,540 $3,257,834

All Filings in BMY

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,257,834 56,540
2026-03-31 $6,065,000 100,000
2025-09-30 $9,015,490 199,900
2025-09-30 $3,341,954 74,101
2025-09-30 $6,765,000 150,000
2025-06-30 $1,305,378 28,200
2025-06-30 $1,008,751 21,792
2025-06-30 $324,030 7,000
2025-03-31 $433,882 7,114
2025-03-31 $9,593,727 157,300
2024-09-30 $4,278,898 82,700
2021-12-31 $2,805,750 45,000
2021-09-30 $3,846,050 65,000